Therefore, modulating PTGS2 expression in melanoma cells, perhaps by using genetic engineering like CRISPR technology, could be transformative to improve success rates in the development of new and highly selective drugs for melanoma treatment. The gene discussed is PTGS2; the disease is melanoma.